Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of a New Sequencing Strategy in Autoinflammatory Siseases (BIOSAID)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Patients with prerequisites established jointly by the reference centers:~* At least 3 unexplained inflammatory access~* Elevated C Reactive Protein~* Age of symtoms less than 30 years and validated by a physician CeréMAI (Centre de référence des maladies autoinflamatoires)~Exclusion Criteria:~* Other inflammatory disease:~* intercurrent infection~* cancer~* autoimmune disease

- Gender: ALL
- Minimum Age: 3 Months
- Maximum Age: 99 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).